Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.88 USD | +0.68% | +5.60% | +55.91% |
May. 13 | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
May. 10 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 76.75M |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -74M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.13
x | P/E ratio 2025 * |
-1.21
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.16% |
1 day | +0.68% | ||
1 week | +5.60% | ||
Current month | +9.80% | ||
1 month | +13.79% | ||
3 months | +3.30% | ||
6 months | +74.45% | ||
Current year | +55.91% |
Managers | Title | Age | Since |
---|---|---|---|
Bronson Crouch
CEO | Chief Executive Officer | 51 | 18-10-31 |
Sandeep Laumas
DFI | Director of Finance/CFO | 56 | 20-05-31 |
Mark Dudley
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Gibson
BRD | Director/Board Member | 67 | 20-05-31 |
Richard McGaughy
BRD | Director/Board Member | 52 | 20-05-31 |
Director/Board Member | 49 | 20-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 11.88 | +0.68% | 11 307 |
24-05-13 | 11.8 | +1.90% | 7,880 |
24-05-10 | 11.58 | +3.12% | 54,820 |
24-05-09 | 11.23 | -0.27% | 32,321 |
24-05-08 | 11.26 | +0.09% | 2,865 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.91% | 76.75M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- TIL Stock